eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiology

Cardiac Tumors: Differential Diagnoses & Workup

Author: Edwin Rodriguez-Cruz, MD, Assistant Professor, Department of Pediatrics, San Juan Bautista Medical School and Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Pediatrics, Hospital El Maestro and San Juan Bautista Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Cardiology, Cardiovascular Center of Puerto Rico and the Caribbean and Veterans Affairs Hospital and Medical Center of Puerto Rico
Coauthor(s): Rosa M Cintrón-Maldonado, MD, Clinical Instructor of Pediatrics, Department of Pediatrics, San Juan Bautista Medical Center; Robert D Ross, MD, Co-Director of Pediatric Cardiology Fellowship Program, Department of Pediatrics, Division of Pediatric Cardiology, Professor, Children's Hospital of Michigan and Wayne State University
Contributor Information and Disclosures

Updated: Nov 10, 2008

Differential Diagnoses

Acidosis, Metabolic
Mitral Stenosis, Acquired
Atrial Septal Defect, General Concepts
Myocarditis, Nonviral
Cardiomyopathy, Hypertrophic
Neonatal Lupus and Cutaneous Lupus Erythematosus in Children
Cardiomyopathy, Restrictive
Pulmonary Hypertension, Idiopathic
Double Outlet Right Ventricle, Normally Related Great Arteries
Pulmonary Stenosis, Infundibular
Double-Chambered Right Ventricle
Pulmonary Stenosis, Valvar
Ebstein Anomaly
Rheumatic Heart Disease
Endocardial Fibroelastosis
Systemic Lupus Erythematosus
Hypoplastic Left Heart Syndrome
Thrombophlebitis
Loffler Syndrome
Vasculitis and Thrombophlebitis

Other Problems to Be Considered

Collagen vascular diseases
Mural thrombus
Cerebrovascular accident
Vasculitis (ie, lupus, polyarteritis)
Mitral valve stenosis

Workup

Laboratory Studies

  • CBC count with differential should be normal in benign cardiac tumors. In malignant tumors, any kind of blood count abnormality can be present in these patients. For example, anemia is not an uncommon finding. Platelet count may be elevated or low, and WBC count may be high.
  • Erythrocyte sedimentation rate (ESR) is a nonspecific marker for inflammation that may be normal or elevated; however, the ESR could be low in the presence of congestive heart failure (CHF).
  • Liver function test findings are occasionally elevated because of severe right-sided heart failure or metastases.
  • Creatine kinase-myocardial band (CK-MB) fraction levels have been found to be higher in patients who have both ventricular dysfunction and a cardiac tumor but not necessarily primary malignancies from the heart.

Imaging Studies

  • Echocardiography
    • This is the most cost-effective of all tests used to evaluate the anatomy of the heart. Echocardiography can provide important information about size, extension and/or invasion within and outside the heart, valvar involvement and/or competency, ventricular function, and pericardial effusion.
    • It is very sensitive but not specific.
    • Some of these tumors may be too small for echocardiographic detection, especially those leading to dysrhythmias.
    • Transesophageal echocardiogram also is useful in detecting tumors in the left heart, especially in adults.
  • Chest roentgenography: Cardiomegaly and pulmonary edema may present in cases of obstructive lesions. Certain neoplasms can have calcium deposition detected on the roentgenogram.
  • MRI: MRI is a powerful tool in diagnosing tumors, evaluating their extent, and seeking metastases. It may delineate the area of the mass better than echocardiography because it has a larger field of observation. Contrast enhancement and multislice imaging can provide a 3-dimensional view of tissue. It also can help differentiate tumors from thrombi.
  • CT scanning: Ultrafast CT scanning is gaining use in this area because it eliminates artifacts of heart motion seen with conventional CT scanning. CT is a powerful tool in evaluating the extent of the tumor and exhibits a high degree of tissue discrimination.

Other Tests

  • ECG: Nonspecific changes are the most common findings; however, ST-T segment changes with strain patterns have been noticed in obstructive rhabdomyomas and fibromas. After surgery, these changes return to normal. Other patterns associated with ischemia also may be present. Diffuse low-voltage QRS, especially in the presence of pericardial effusion, can be seen. Arrhythmias may be the first presentation of an intracardiac tumor and occasionally are resistant to medical therapy. Other findings include intraventricular conduction delay and complete bundle branch block.

Procedures

  • Endomyocardial biopsy is controversial and seldom useful in children because of the high possibility of false-negative results and the high possibility of metastasis during the procedure if a malignant tumor is present.

Histologic Findings

Benign tumors

Rhabdomyomas are a glycogenic degeneration of myocardial fibers and are thus considered hamartomas. They contain large vacuolated cells filled with glycogen. Their microscopic hallmark, the spider cell, displays eccentric nuclei, granular cytoplasm with a central cytoplasmic mass, and fine fibrillar processes that radiate to the periphery, giving the appearance of a spider in a web. Because the cytoplasm is rich in glycogen, it stains positive with periodic acid-Schiff reagent. Rhabdomyositis is a rare form of cardiomyopathy. In this pathology, microscopic changes in the muscle and conduction system are evident, yet gross anatomic findings are rare.

Cardiac fibromas consist of elongated fibroblasts, with fibrous tissue and collagen. Occasionally, calcium can be seen using radiography or microscopically within the tumor. Mitosis is rarely seen in this type of tumor.

Myxoma has a characteristic pattern of cells termed lipidic cells embedded in a myxoid stroma rich in glycosaminoglycans. These cells are multinucleated with pink cytoplasm. Typically, they present in clusters surrounding vascular structures. Calcium is present in approximately 10% of patients. Usually, the embolized material has a different pattern from the material at the center of the lesion, and cells resemble embryonic mesenchymal cells, similar to embryonic endocardial cushion tissue.

Teratomas, rarely malignant in children, form from 3 embryonic tissues that usually grow in the anterior mediastinum. These tumors should be differentiated from intrapericardial bronchogenic cysts because they may have the same gross appearance; the histologic difference is that bronchogenic cysts do not contain neuronal tissue, which is usually present in teratomas.

Hemangiomas are classified, based on the predominant type of proliferating vascularity, into hemangiomas (common) or lymphangiomas (extremely uncommon). The tumor contains endothelium-lined spaces that may have blood, lymph, or thrombi.

Malignant tumors

Angiosarcomas have variable vascular channels lined with atypical endothelial cells.

The histologic hallmark of rhabdomyosarcoma is the presence of cross-striations.

Fibrosarcomas are composed of a herringbone pattern of spindle-shaped cells with elongated blunt-ended nuclei and frequent mitoses.

More on Cardiac Tumors

Overview: Cardiac Tumors
Differential Diagnoses & Workup: Cardiac Tumors
Treatment & Medication: Cardiac Tumors
Follow-up: Cardiac Tumors
Multimedia: Cardiac Tumors
References

References

  1. Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. Oct 1993;117(10):1027-31. [Medline].

  2. Kono T, Koide N, Hama Y, et al. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: a study of fifteen patients. J Thorac Cardiovasc Surg. Jan 2000;119(1):101-7. [Medline].

  3. Butany J, Nair V, Naseemuddin A, et al. Cardiac tumours: diagnosis and management. Lancet Oncol. Apr 2005;6(4):219-28. [Medline].

  4. Dhillon G, Rodriguez-Cruz E, Kathawala M, Alqassem N. Primary cardiac myofibroblastic sarcoma, case report and review of diagnosis and treatment of cardiac tumors. Bol Asoc Med P R. Jul-Dec 1998;90(7-12):130-3. [Medline].

  5. Farooki ZQ, Ross RD, Paridon SM, et al. Spontaneous regression of cardiac rhabdomyoma. Am J Cardiol. Apr 15 1991;67(9):897-9. [Medline].

  6. Gaumann A, Strubel G, Bode-Lesniewska B, Schmidtmann I, Kriegsmann J, Kirkpatrick CJ. The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery. Oncol Rep. Aug 2008;20(2):309-18. [Medline].

  7. Le Guyader A, Laskar M. Removal of left ventricular tumors by a transaortic transvalvular approach with the help of thoracoscopic instruments. J Thorac Cardiovasc Surg. Aug 2008;136(2):537-8. [Medline].

  8. Lopez M, Pinto A, Moreno V, Diaz M, Gonzalez Baron A. Primary cardiac osteosarcoma. Clin Transl Oncol. Aug 2008;10(8):515-6. [Medline].

  9. Ludomirsky A. Cardiac tumors. In: Bricker JT, Fisher DJ, eds. The Science and Practice of Pediatric Cardiology. Vol 2. 9th ed. Williams & Wilkins; 1998:1885-93.

  10. Martinez Quesada M, Trujillo Berraquero F, Almendro Delia M, et al. [Cardiac hamartoma. Case report and literature review]. Rev Esp Cardiol. Apr 2005;58(4):450-2. [Medline].

  11. Marx GR. Cardiac Tumors. In: Emmanouilides GC, Gutgesell HP, Riemenschneider TA, Allen HD, eds. Moss and Adams Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. Vol 2. 5th ed. Baltimore, MD: Williams & Wilkins; 1995:1773-86.

  12. McAllister HA, Fenoglio JJ Jr. Tumors of the cardiovascular system: atlas of tumor pathology, second series. In: Washington, DC: Armed Forces Institute of Pathology. 1978.

  13. Padalino MA, Basso C, Milanesi O, et al. Surgically treated primary cardiac tumors in early infancy and childhood. J Thorac Cardiovasc Surg. Jun 2005;129(6):1358-63. [Medline].

  14. Piazza N, Chughtai T, Toledano K, et al. Primary cardiac tumours: eighteen years of surgical experience on 21 patients. Can J Cardiol. Dec 2004;20(14):1443-8. [Medline].

  15. Rodriguez-Cruz E, Cintron-Maldonado RM, Bercu BA. Primary cardiac osteogenic sarcoma treated with heart transplantation. Bol Asoc Med PR. 1999;91 (7-12):98-99. [Medline].

  16. Rodriguez-Cruz E, Cintron-Maldonado RM, Forbes TJ. Treatment of primary cardiac malignancies with orthotopic heart transplantation. Bol Asoc Med P R. Apr-Aug 2000;92(4-8):65-71. [Medline].

  17. Takach TJ, Reul GJ, Ott DA, Cooley DA. Primary cardiac tumors in infants and children: immediate and long-term operative results. Ann Thorac Surg. Aug 1996;62(2):559-64. [Medline].

  18. Tatli S, Lipton MJ. CT for intracardiac thrombi and tumors. Int J Cardiovasc Imaging. Feb 2005;21(1):115-31. [Medline].

  19. Tazelaar HD, Locke TJ, McGregor CG. Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc. Oct 1992;67(10):957-65. [Medline].

  20. Wu XM, Hu CZ, Li N, et al. [Relationship of serum level of creatine kinase of MB type to cardiac function of patients with advanced tumors and its prognostic value]. Ai Zheng. Apr 2005;24(4):506-8.abs. [Medline].

Further Reading

Keywords

cardiac tumors, cardiac neoplasm, heart tumors, heart neoplasm, neoplasm of the heart, rhabdomyoma, fibroma, myxoma, teratoma, sarcoma, angiosarcoma, cancer, cardiac mass, congenital heart failure, CHF, jugular venous distention, ascites, pericardial effusion, syncope, shortness of breath, vena cava syndrome, pulmonary embolism, restrictive cardiomyopathy, tuberous sclerosis, Carney syndrome, vascular tumors, hemangiomas, lymphangiomas, heart block, lipomas, papillary tumors, leiomyomas, mesotheliomas, fibroelastomas, fibroelastic papillomas, benign cystic tumors, rhabdomyosarcoma

Contributor Information and Disclosures

Author

Edwin Rodriguez-Cruz, MD, Assistant Professor, Department of Pediatrics, San Juan Bautista Medical School and Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Pediatrics, Hospital El Maestro and San Juan Bautista Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Cardiology, Cardiovascular Center of Puerto Rico and the Caribbean and Veterans Affairs Hospital and Medical Center of Puerto Rico
Edwin Rodriguez-Cruz, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Medical Association, American Society of Echocardiography, Puerto Rico Medical Association, Society of Cardiac Angiography and Interventions, and Society of Pediatric Echocardiography
Disclosure: Nothing to disclose.

Coauthor(s)

Rosa M Cintrón-Maldonado, MD, Clinical Instructor of Pediatrics, Department of Pediatrics, San Juan Bautista Medical Center
Rosa M Cintrón-Maldonado, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Robert D Ross, MD, Co-Director of Pediatric Cardiology Fellowship Program, Department of Pediatrics, Division of Pediatric Cardiology, Professor, Children's Hospital of Michigan and Wayne State University
Robert D Ross, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, and Society of Pediatric Echocardiography
Disclosure: Nothing to disclose.

Medical Editor

Jeffrey Allen Towbin, MD, MSc, FAAP, FACC, FAHA, Professor, Departments of Pediatrics (Cardiology), Cardiovascular Sciences, and Molecular and Human Genetics, Baylor College of Medicine; Chief of Pediatric Cardiology, Foundation Chair in Pediatric Cardiac Research, Texas Children's Hospital
Jeffrey Allen Towbin, MD, MSc, FAAP, FACC, FAHA is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American College of Cardiology, American College of Sports Medicine, American Heart Association, American Medical Association, American Society of Human Genetics, Cardiac Electrophysiology Society, Heart Rhythm Society, New York Academy of Sciences, Society for Pediatric Research, Texas Medical Association, and Texas Pediatric Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Ameeta Martin, MD, Clinical Associate Professor, Department of Pediatric Cardiology, University of Nebraska College of Medicine
Ameeta Martin, MD is a member of the following medical societies: American College of Cardiology
Disclosure: Nothing to disclose.

CME Editor

Gilbert Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College
Gilbert Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Steven R Neish, MD, SM, Director of Pediatric Cardiology Fellowship Program, Associate Professor, Department of Pediatrics, Baylor College of Medicine
Steven R Neish, MD, SM is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and American Heart Association
Disclosure: Nothing to disclose.

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.